Monument Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Monument Capital Management's AMGN Position: Q2 2026 in Review
Monument Capital Management reduced its Amgen (AMGN) stake by 2% in Q2 2026, selling an estimated $17.8K and leaving 2,614 shares worth $947K. The position accounts for 0.19% of the portfolio, ranked #115.
Monument Capital Management first reported a position in AMGN in Q3 2018 and has held it in 27 quarters since. The position peaked at $2.24M in Q3 2020. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Monument Capital Management held 2,614 shares of Amgen worth $947K as of Q2 2026.
- Monument Capital Management sold 52 Amgen shares in Q2 2026, an estimated $17.8K.
- Amgen made up 0.19% of Monument Capital Management's portfolio in Q2 2026, its #115 holding.
- Monument Capital Management first reported a position in Amgen in Q3 2018 and has held it in 27 quarters since.
- Monument Capital Management's Amgen position peaked at $2.24M in Q3 2020.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Monument Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.